BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16234970)

  • 1. Novel assessment of bone using time-resolved transcutaneous Raman spectroscopy.
    Draper ER; Morris MD; Camacho NP; Matousek P; Towrie M; Parker AW; Goodship AE
    J Bone Miner Res; 2005 Nov; 20(11):1968-72. PubMed ID: 16234970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta.
    Bart ZR; Hammond MA; Wallace JM
    Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
    Camacho NP; Carroll P; Raggio CL
    Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
    Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
    Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density.
    Phillips CL; Bradley DA; Schlotzhauer CL; Bergfeld M; Libreros-Minotta C; Gawenis LR; Morris JS; Clarke LL; Hillman LS
    Bone; 2000 Aug; 27(2):219-26. PubMed ID: 10913914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering.
    Fratzl P; Paris O; Klaushofer K; Landis WJ
    J Clin Invest; 1996 Jan; 97(2):396-402. PubMed ID: 8567960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative polarized Raman spectroscopy in highly turbid bone tissue.
    Raghavan M; Sahar ND; Wilson RH; Mycek MA; Pleshko N; Kohn DH; Morris MD
    J Biomed Opt; 2010; 15(3):037001. PubMed ID: 20615030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy.
    Camacho NP; Landis WJ; Boskey AL
    Connect Tissue Res; 1996; 35(1-4):259-65. PubMed ID: 9084664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman and Fourier Transform Infrared (FT-IR) Mineral to Matrix Ratios Correlate with Physical Chemical Properties of Model Compounds and Native Bone Tissue.
    Taylor EA; Lloyd AA; Salazar-Lara C; Donnelly E
    Appl Spectrosc; 2017 Oct; 71(10):2404-2410. PubMed ID: 28485618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
    Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
    J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.
    Miller E; Delos D; Baldini T; Wright TM; Pleshko Camacho N
    Calcif Tissue Int; 2007 Sep; 81(3):206-14. PubMed ID: 17660935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model.
    McCarthy EA; Raggio CL; Hossack MD; Miller EA; Jain S; Boskey AL; Camacho NP
    Pediatr Res; 2002 Nov; 52(5):660-70. PubMed ID: 12409511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overconstrained library-based fitting method reveals age- and disease-related differences in transcutaneous Raman spectra of murine bones.
    Maher JR; Inzana JA; Awad HA; Berger AJ
    J Biomed Opt; 2013 Jul; 18(7):077001. PubMed ID: 23817761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The material basis for reduced mechanical properties in oim mice bones.
    Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
    J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
    Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
    Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.
    Delos D; Yang X; Ricciardi BF; Myers ER; Bostrom MP; Camacho NP
    J Orthop Res; 2008 Feb; 26(2):153-64. PubMed ID: 17729310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.
    Misof K; Landis WJ; Klaushofer K; Fratzl P
    J Clin Invest; 1997 Jul; 100(1):40-5. PubMed ID: 9202055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.